NCT05479968View on ClinicalTrials.gov

Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

January 24, 2022

Study Completion Date

January 24, 2022

Conditions
Coronary Artery DiseaseHeart Valve Diseases
Interventions
DEVICE

Spectrocor device

This feasibility study is intended to document the feasibility, safety, and usability of the Investigational device.

Trial Locations (1)

00029

Heart and Lung Center, Helsinki

All Listed Sponsors
collaborator

Hospital District of Helsinki and Uusimaa

OTHER

lead

Spectrocor

INDUSTRY

NCT05479968 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery | Biotech Hunter | Biotech Hunter